This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US DOJ's proposed trial schedule in UnitedHealth-Change Healthcare challenge 'seems excessive,' companies say

( March 11, 2022, 23:15 GMT | Official Statement) -- MLex Summary: The Department of Justice's proposal to take more than two weeks to present its case in the agency's challenge to UnitedHealth's acquisition of Change Healthcare "seems excessive" given the issues in the case, counsel for the defendants said. The companies say that Change Healthcare's planned divestiture of its claims-editing business will ensure that UHG never takes control of the business the DOJ alleges will give it a monopoly, significantly narrowing the issues for discovery and trial.See document attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections